Vienna-based Flinn.ai has secured $20 million in a Series A round led by HV Capital to automate regulatory and quality compliance for medical device and pharmaceutical companies. The funding will fuel its expansion into the US market and extend its AI platform across the entire product lifecycle.
Cyber News Centre's AI startup update for 25th February 2026: Flinn.ai, a Vienna-based company developing an AI platform for medical device and pharmaceutical compliance, has secured $20 million in a Series A funding round.
Flinn.ai provides an AI-driven platform that automates quality and regulatory processes for manufacturers in the MedTech and pharmaceutical sectors. The software streamlines the entire product lifecycle, from R&D to post-market surveillance, helping companies navigate complex compliance frameworks like Europe's MDR and IVDR.
Update: Vienna-based Flinn.ai has secured $20 million in a Series A funding round led by HV Capital, with participation from US healthcare investor BHI – Bertelsmann Healthcare Investments, and existing backers Cherry Ventures, Speedinvest, and SquareOne.
The investment will be used to expand the company's AI platform across the entire medical product lifecycle, from research and development to commercial processes, and to support its entry into the US market. Flinn.ai's software automates workflows for post-market surveillance, literature evaluation, and complaint handling, replacing manual, document-heavy processes. The company counts Carl Zeiss, Philips, and Paul Hartmann among its clients.
"Our software is designed to replace manual, document-heavy workflows with automated systems that scale across products, markets, and regulatory regimes," said Bastian Krapinger-Rüther, Co-Founder and Co-CEO of Flinn.ai.
The new funding brings the company's total raised to approximately $30 million.
Why it Matters: The funding addresses a significant pain point in the multi-billion dollar medical device industry: the high cost and complexity of regulatory compliance. Adhering to standards like Europe's Medical Device Regulation (MDR) can cost manufacturers tens of thousands of dollars per product certification, creating a substantial barrier to innovation.
By automating these processes, Flinn.ai's platform can reduce administrative overhead, shorten development timelines, and lower the risk of non-compliance. This allows MedTech and pharmaceutical companies to allocate resources more effectively towards innovation and product development, ultimately accelerating the delivery of new healthcare solutions to market.
Get the stories that matter to you.
Subscribe to Cyber News Centre and update your preferences to follow our Daily 4min Cyber Update, Innovative AI Startups, The AI Diplomat series, or the main Cyber News Centre newsletter — featuring in-depth analysis on major cyber incidents, tech breakthroughs, global policy, and AI developments.
The AI gold rush is shifting from dazzling tools to industrial infrastructure. As inference becomes the engine room of finance, cyber security and enterprise decision-making, the real winners will be those that make intelligence fast, reliable, scalable and affordable, not merely impressive
Liquid Instruments has raised $70 million to scale its AI driven Moku platform globally, backing Australia’s deep tech ambitions while helping engineers in defence, space, semiconductors and quantum computing replace rigid hardware with adaptable software defined tools.
Atlanta-based Stord has announced a $250 million Series F funding round at a $3 billion valuation, cementing its position as
New York's Reflexivity raises $30M Series B backed by Interactive Brokers, bringing AI co-pilot investment research to millions of traders globally.
Where cybersecurity meets innovation, the CNC team delivers AI and tech breakthroughs for our digital future. We analyze incidents, data, and insights to keep you informed, secure, and ahead. Sign up for free!
